Secukinumab 300mg/2ml solution for injection pre-filled disposable devices
NHS hospitals in England used £127,964,587 of indicative cost of Secukinumab 300mg/2ml solution for injection pre-filled disposable devices in the 12 months to July 2026, about 0.5% of all hospital medicines spend. That is up 13.6% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Secukinumab 300mg/2ml solution for injection pre-filled disposable devices: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Secukinumab 300mg/2ml solution for injection pre-filled disposable devices most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Luton & Dunstable Hospital Trust | £3,550,306 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £3,421,115 |
| Western Sussex Hospitals Nhs Found Trust | £3,250,486 |
| Co.durham & Darlington Nhs Foundation Tr | £3,155,421 |
| Aintree University Hospital Nhs Ft | £3,120,077 |
| Salford Royal Nhs Foundation Trust | £3,085,951 |
| Derby Teaching Hospitals Nhs Found Trust | £2,986,011 |
| Leeds Teaching Hpls Nhs Trust | £2,984,792 |
| Gloucestershire Hpls Nhs Foundation Trst | £2,800,756 |
| Colchester Hospital University Nhs Ft | £2,567,969 |
The primary-care picture
Secukinumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Secukinumab medicine page.